Clough Capital Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,057,124
| Closed | -$4.11M | – | 136 |
|
|
2019
Q3 | $4.11M | Sell |
2,057,124
-27,700
| -1% | -$55.4K | 0.34% | 55 |
|
|
2019
Q2 | $4.5M | Sell |
2,084,824
-26,400
| -1% | -$57K | 0.44% | 69 |
|
|
2019
Q1 | $6.67M | Sell |
2,111,224
-261,000
| -11% | -$825K | 0.58% | 62 |
|
|
2018
Q4 | $5.91M | Buy |
2,372,224
+232,930
| +11% | +$580K | 0.69% | 56 |
|
|
2018
Q3 | $8.6M | Buy |
2,139,294
+77,031
| +4% | +$310K | 0.81% | 45 |
|
|
2018
Q2 | $7.8M | Sell |
2,062,263
-13,400
| -0.6% | -$50.7K | 0.7% | 48 |
|
|
2018
Q1 | $4.82M | Sell |
2,075,663
-591,922
| -22% | -$1.37M | 0.46% | 62 |
|
|
2017
Q4 | $4.14M | Sell |
2,667,585
-211,400
| -7% | -$328K | 0.34% | 69 |
|
|
2017
Q3 | $6.13M | Hold |
2,878,985
| – | – | 0.41% | 63 |
|
|
2017
Q2 | $13M | Sell |
2,878,985
-79,430
| -3% | -$359K | 0.9% | 36 |
|
|
2017
Q1 | $8.91M | Sell |
2,958,415
-102,649
| -3% | -$309K | 0.57% | 55 |
|
|
2016
Q4 | $8.45M | Hold |
3,061,064
| – | – | 0.56% | 57 |
|
|
2016
Q3 | $9.58M | Buy |
3,061,064
+1,000,000
| +49% | +$3.13M | 0.5% | 70 |
|
|
2016
Q2 | $10.6M | Buy |
2,061,064
+16,411
| +0.8% | +$84K | 0.56% | 63 |
|
|
2016
Q1 | $8.36M | Buy |
2,044,653
+306,300
| +18% | +$1.25M | 0.39% | 77 |
|
|
2015
Q4 | $14.1M | Buy |
1,738,353
+154,270
| +10% | +$1.25M | 0.66% | 51 |
|
|
2015
Q3 | $13.4M | Buy |
1,584,083
+796,500
| +101% | +$6.72M | 0.58% | 59 |
|
|
2015
Q2 | $7.41M | Buy |
787,583
+190,400
| +32% | +$1.79M | 0.28% | 94 |
|
|
2015
Q1 | $5.53M | Buy |
597,183
+84,650
| +17% | +$784K | 0.18% | 127 |
|
|
2014
Q4 | $4.74M | Buy |
512,533
+13,529
| +3% | +$125K | 0.17% | 123 |
|
|
2014
Q3 | $4.46M | Buy |
499,004
+138,283
| +38% | +$1.23M | 0.17% | 119 |
|
|
2014
Q2 | $2.83M | Buy |
+360,721
| New | +$2.83M | 0.09% | 147 |
|